Picture of Probiotec logo

PBP — Probiotec News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedSmall Cap

Brief: Probiotec Expects FY22 Underlying EBITDA Of A$32 Mln-A$33 Mln

Feb 25 (Reuters) - Probiotec Ltd  PBP.AX :
    * FY22 GUIDANCE UPDATE
    * SEES FY22 REVENUE OF BETWEEN A$175 MILLION AND A$180
MILLION
    * SEES FY22 UNDERLYING EBITDA OF BETWEEN A$32 MILLION AND
A$33
MILLION

Source text for Eikon:  ID:nASX7Gv0Yb 
Further company coverage:  PBP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Probiotec

See all news